TR200301552A1 - Rofekoksib' in yeni oral farmakolojik formülasyonları. - Google Patents

Rofekoksib' in yeni oral farmakolojik formülasyonları.

Info

Publication number
TR200301552A1
TR200301552A1 TR2003/01552A TR200301552A TR200301552A1 TR 200301552 A1 TR200301552 A1 TR 200301552A1 TR 2003/01552 A TR2003/01552 A TR 2003/01552A TR 200301552 A TR200301552 A TR 200301552A TR 200301552 A1 TR200301552 A1 TR 200301552A1
Authority
TR
Turkey
Prior art keywords
rofecoxib
novel oral
pharmacological formulations
oral pharmacological
formulations
Prior art date
Application number
TR2003/01552A
Other languages
English (en)
Inventor
Uslu Abdullah
Original Assignee
Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. filed Critical Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş.
Priority to TR2003/01552A priority Critical patent/TR200301552A1/tr
Priority to PCT/TR2004/000039 priority patent/WO2005025564A1/en
Publication of TR200301552A1 publication Critical patent/TR200301552A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu buluş rofekoksib etken içeren ve bu etken maddenin oral yolla alınmasını sağlayan yeni farmasötik dozaj formlarını hazırlamak için geliştirilen yeni yöntem ile ilgilidir. Geliştirilen bu formülasyon ile rofekoksibin dissolüsyon ve invivo özelliklerine üstünlük kazandırılmıştır.
TR2003/01552A 2003-09-18 2003-09-18 Rofekoksib' in yeni oral farmakolojik formülasyonları. TR200301552A1 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2003/01552A TR200301552A1 (tr) 2003-09-18 2003-09-18 Rofekoksib' in yeni oral farmakolojik formülasyonları.
PCT/TR2004/000039 WO2005025564A1 (en) 2003-09-18 2004-09-16 Oral pharmaceutical formulations of rofecoxib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2003/01552A TR200301552A1 (tr) 2003-09-18 2003-09-18 Rofekoksib' in yeni oral farmakolojik formülasyonları.

Publications (1)

Publication Number Publication Date
TR200301552A1 true TR200301552A1 (tr) 2005-10-21

Family

ID=34311481

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01552A TR200301552A1 (tr) 2003-09-18 2003-09-18 Rofekoksib' in yeni oral farmakolojik formülasyonları.

Country Status (2)

Country Link
TR (1) TR200301552A1 (tr)
WO (1) WO2005025564A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3119728A1 (en) 2018-11-21 2020-05-28 Tremeau Pharmaceuticals, Inc. Purified forms of rofecoxib, methods of manufacture and use
US10945992B1 (en) * 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284330B6 (sk) * 1996-05-17 2005-01-03 Merck & Co., Inc. Použitie 3-fenyl-4-(4-metylsulfonyl)fenyl)-2-(5H)-furanónu
EA008242B1 (ru) * 1999-12-08 2007-04-27 Фармация Корпорейшн Композиции на основе ингибитора циклооксигеназы-2 с быстро наступающим терапевтическим действием и способы лечения заболеваний
AU2002236120A1 (en) * 2001-02-27 2002-09-12 Ranbaxy Laboratories Limited Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
WO2003086343A2 (en) * 2002-04-05 2003-10-23 Cadila Healthcare Limited Fast disintegrating oral dosage forms

Also Published As

Publication number Publication date
WO2005025564A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
SE0001899D0 (sv) New compounds
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
ATE292453T1 (de) Antivirale arznei
SE0401342D0 (sv) Therapeutic compounds
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
TW200603787A (en) Topical preparations containing ambroxol
SE0102440D0 (sv) New compound
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE50005082D1 (de) Verfahren zu Herstellung von PULVERFÖRMIGEn SOLUBILISATIONSHILFSSTOFFEn FÜR FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
SE0001916D0 (sv) Novel formulation
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler